An innovative approach to correcting representativeness biases
Doctrinal position on the paradigm shift represented by using generative AI to correct representativeness biases in clinical cohorts, as an alternative to the systematic exclusion of under-represented populations.
Identifying and correcting biases in patient cohorts for clinical trials is a structural challenge in biomedical research. Traditionally, the presence of biases led to the exclusion of entire populations, reducing the generalizability of results. This approach is particularly counterproductive in the frequent case of small cohorts, where information loss compromises statistical analysis.
This article proposes a paradigm shift: using generative artificial intelligence to augment and rebalance cohorts rather than rejecting them. This is what the Smart Data Fertilizer module of the TweenMe platform achieves.
The document establishes an operational taxonomy distinguishing three families of biases: selection biases (recruitment, participation, survival), measurement and classification biases (detection, differential classification), and temporal and contextual biases (evolving clinical practices, geographic variations in healthcare systems).
The methodological approach decomposes into three phases: multidimensional bias diagnosis combining unsupervised clustering, conditional independence tests, algorithmic fairness metrics and high-dimensional visualization (t-SNE, UMAP); guided generative modeling combining conditional GANs for continuous variables, fine-tuned Transformers for categorical variables, and autoregressive models with temporal attention for clinical sequences; and multi-criteria validation covering clinical coherence, statistical indistinguishability, multivariate correlation preservation and treatment effect impact.
The toolbox covers adaptive SMOTE, Borderline-SMOTE and ADASYN for rebalancing, XGBoost with SHAP analysis for guided feature selection, and Transformer architectures with specialized medical attention mechanisms integrating prior knowledge on drug interactions, pathological progressions and temporal constraints.
The article describes the concrete implementation within the TweenMe ecosystem: quality validation pipeline with multi-source ingestion and bias scoring, adaptive generation engine with automatic model selection and hard/soft clinical constraints, and collaborative interface with interactive dashboard and full traceability for regulatory compliance (ICH-GCP, GDPR, FDA/EMA).
Future developments include integrating causal graphs (DAGs) into generative models, generating clinical counterfactuals, federated learning for decentralization, and standardizing exchange formats for generative models across institutions.